e-learning
resources
Munich 2006
Monday 04.09.2006
Community-acquired pneumonia: risk factors and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course
T. V. Rubanik, N. L. Shaporova, V. I. Trofimov (Saint-Petersburg, Russian Federation)
Source:
Annual Congress 2006 - Community-acquired pneumonia: risk factors and treatment
Session:
Community-acquired pneumonia: risk factors and treatment
Session type:
Poster Discussion
Number:
2096
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. V. Rubanik, N. L. Shaporova, V. I. Trofimov (Saint-Petersburg, Russian Federation). The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course. Eur Respir J 2006; 28: Suppl. 50, 2096
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
The main risk factors of the community-acquired pneumonia delayed course
Source: Eur Respir J 2005; 26: Suppl. 49, 643s
Year: 2005
COPD is associated with increased mortality in patients with community-acquired pneumonia
Source: Eur Respir J 2006; 28: 346-351
Year: 2006
Risk factors for early onset severe community-acquired pneumonia complications
Source: International Congress 2018 – Pleural diseases and pneumonia: what's new ?
Year: 2018
Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia?
Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know?
Year: 2008
The impact of patients‘ age and concomitant diseases on community-acquired pneumonia outcome
Source: Eur Respir J 2007; 30: Suppl. 51, 675s
Year: 2007
Treatment failure of community-acquired pneumonia: risk factors and consequences
Source: Annual Congress 2012 - PG17 Clinical failure of treatment of respiratory infections
Year: 2012
The tobacco-smoking influence on the community-acquired pneumonia course
Source: Eur Respir J 2006; 28: Suppl. 50, 247s
Year: 2006
The possibility to predict the danger of destabilization development of the ischemic heart disease course in patients with community-acquired pneumonia infected with chlamydophila pneumonia
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Management-based risk prediction in community-acquired pneumonia by scores and biomarkers
Source: Eur Respir J 2013; 41: 974-984
Year: 2013
Risk factors for pulmonary tuberculosis in community-acquired pneumonia
Source: Eur Respir J 2014; 43: 1214
Year: 2014
Risk factors for pulmonary tuberculosis in community-acquired pneumonia
Source: Eur Respir J 2014; 43: 1213
Year: 2014
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2012; 39: 187-196
Year: 2012
Is community-acquired pneumonia an independent risk factor for cardiovascular disease?
Source: Eur Respir J 2011; 39: 187-196
Year: 2012
Initial and persistent inflammatory response in treatment failure in community-acquired pneumonia
Source: Annual Congress 2007 - Prognostic laboratory tests in community-acquired pneumonia
Year: 2007
The influence of chronic concomitant diseases and age on the risk of death in patients with community-aquired pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 354s
Year: 2002
Inflammatory responses predict long-term mortality risk in community-acquired pneumonia
Source: Eur Respir J 2011; 37: 1439-1446
Year: 2011
Community-acquired pneumonia in COPD patients: GOLD staging is a strong predicting factor of outcome of pneumonia
Source: Annual Congress 2010 - Colonisation and infection in COPD
Year: 2010
Oropharyngeal dysphagia is a risk factor for community-acquired pneumonia in the elderly
Source: Eur Respir J 2013; 41: 923-928
Year: 2013
Impact of neutrophil function on outcomes of community-acquired pneumonia in patients with cancer
Source: Eur Respir Rev 2008; 17: 83-85
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept